IN-015

N/A

Report date: 2025/03/03 10:50:46

Base Information

Drug NameIN-015
Drug Alias NameIN015IN-015
ClassificationCell and gene therapy > Gene therapy > mRNA
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsProgressive familial intrahepatic cholestasis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesInnorna Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesInnorna Co Ltd
Inactive CompaniesN/A
Active IndicationsProgressive familial intrahepatic cholestasis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A